# US 2021/0079408 A1 · Biological methods for preparing terpenes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079408 A1
- Document ID: US20210079408A1
- Status: Published application
- Kind: A1
- Application number: 16/630,567
- Filed: 2018-07-11
- Published: 2021-03-18
- Earliest claimed: 2017-07-13
- Assignees: Radici Chimica S.p.A.
- Applicants: Radici Chimica S.p.A.
- Inventors: Kimberly Ann Aeling; Pierre-Yves De Wals; Eric Scott; Eric Knight; Jian Yi; Michael Waldbridge; Thomas Beardslee
- Web page: https://patentgrep.com/patent/US20210079408A1

## CPC

- C12N 15/815: {for yeasts other than Saccharomyces}
- C12N 1/16: Yeasts; Culture media therefor
- C12N 15/09: Recombinant DNA-technology
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12P 7/44: Polycarboxylic acids
- C12P 23/00: Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing heterorings C12P17/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The technology relates in part to biological methods for producing terpenes and to engineered cells and microorganisms capable of such production.

## Claims

### Claim at position 1

1-162. (canceled)

### Claim 163

A genetically modified microorganism, comprising:
one or more heterologous nucleic acids encoding one or more terpene biosynthesis polypeptides, wherein expression of at least one of the heterologous nucleic acids is regulated by a nucleic acid that provides for fatty acid or alkane induction of expression of the terpene biosynthesis polypeptide:
wherein the one or more heterologous nucleic acids that encode one or more terpene biosynthesis polypeptides is chosen from terpene synthase, phytoene synthase, geranylgeranyl diphosphate synthase, phytoene desaturase, lycopene cyclase, bifunctional lycopene cyclase/phytoene synthase, β-carotene ketolase, β-carotene hydroxylase, astaxanthin synthase, zeaxanthin glucosyltransferase and valencene synthase, or
wherein the one or more heterologous nucleic acids is a cytochrome P450 reductase and is regulated by a nucleic acid that provides for alkane induction of expression of the cytochrome P450 reductase.

### Claim 164 (depends on 163)

The microorganism of claim 163, wherein the microorganism is a yeast selected from Candida spp, Yarrowia spp, Rhodotorula spp, Rhodosporidium spp, Cryptococcus spp, Trichosporon spp, Lipomyces spp, and Blastobotrys spp.

### Claim 165 (depends on 164)

The microorganism of claim 164, wherein the fatty acid is a saturated fatty acid or an unsaturated fatty acid selected from one or more of oleic acid, palmitoleic acid, erucic acid, linoleic acid, palmitic acid, caproic acid, enanthic acid, caprylic acid pelargonic acid, capric acid, undecylic acid, lauric acid, myristic acid, pentadecanoic acid, margaric acid, stearic acid arachidic acid, behenic acid, tridecylic acid, and linolenic acid, and wherein the alkane is selected from one or more of hexane, heptane, nonane, decane, undecane, dodecane, tridecane, tetradecane, pentadecane, hexadecane, heptadecane, and octadecane.

### Claim 166

A genetically modified microorganism, comprising
one or more heterologous nucleic acids encoding one or more terpene biosynthesis polypeptides, and
a genetic modification that alters the expression of a polypeptide providing for transport of acetyl-carnitine in the microorganism,
wherein the expression of at least one of the heterologous nucleic acids is regulated by a nucleic acid that provides for glucose, fatty acid or alkane induction of expression of the terpene biosynthesis polypeptide.

### Claim 167 (depends on 166)

The genetically modified microorganism of claim 166, wherein
the microorganism is a fungus selected from Candida spp, Yarrowia spp, Rhodotorula spp, Rhodosporidium spp, Cryptococcus spp, Trichosporon spp, Lipomyces spp, and Blastobotrys spp.

### Claim 168 (depends on 166)

The genetically modified microorganism of claim 166, wherein the one or more heterologous nucleic acids encode one or more terpene biosynthesis polypeptides selected from terpene synthase, phytoene synthase, geranylgeranyl diphosphate synthase, phytoene desaturase, lycopene cyclase, bifunctional lycopene cyclase/phytoene synthase, β-carotene ketolase, β-carotene hydroxylase, astaxanthin synthase, zeaxanthin glucosyltransferase, valencene synthase, and cytochrome p450 reductase.

### Claim 169 (depends on 166)

The microorganism of claim 166, wherein the microorganism has been genetically modified to increase expression of an endogenous ERG20 gene, wherein expression of ERG20 is regulated by a promoter region of the gene encoding oleate-induced peroxisomal protein (POX18), and wherein expression of ERG20 is regulated by a terminator region of the gene encoding oleate-induced peroxisomal protein (POX18).

### Claim 170

A genetically modified Candida viswanathii yeast, comprising one or more heterologous nucleic acids encoding one or more terpene biosynthesis polypeptides, wherein expression of at least one of the heterologous nucleic acids is regulated by a nucleic acid that provides for glucose, fatty acid or alkane induction of expression of the terpene biosynthesis polypeptide and
wherein the one or more heterologous nucleic acids encoding one or more terpene biosynthesis polypeptides is selected from terpene synthase, phytoene synthase, geranylgeranyl diphosphate synthase, phytoene desaturase, lycopene cyclase, bifunctional lycopene cyclase/phytoene synthase, β-carotene ketolase, β-carotene hydroxylase, astaxanthin synthase, zeaxanthin glucosyltransferase and valencene synthase, or
wherein the one or more heterologous nucleic acids is a cytochrome P450 reductase and is regulated by a nucleic acid that provides for glucose or alkane induction of expression of the cytochrome P450 reductase.

### Claim 171 (depends on 170)

The genetically modified Candida viswanathii yeast of claim 170, wherein the one or more heterologous nucleic acids encode phytoene synthase, geranylgeranyl diphosphate synthase and phytoene desaturase.

### Claim 172 (depends on 171)

The genetically modified Candida viswanathii yeast of claim 171, wherein expression of the heterologous nucleic acids encoding phytoene synthase, geranylgeranyl diphosphate synthase and phytoene desaturase is regulated by a promoter region of the gene encoding a Candida hydratase-dehydrogenase-epimerase (HDE), wherein expression of the heterologous nucleic acids encoding phytoene synthase, geranylgeranyl diphosphate synthase and phytoene desaturase is regulated by a terminator region of the gene encoding a Candidaacyl co-A oxidase 4 (POX4), wherein expression of the heterologous nucleic acids encoding phytoene synthase, geranylgeranyl diphosphate synthase and phytoene desaturase is regulated by a promoter region of the gene encoding a Candida glyceraldehyde-3-phosphate dehydrogenase (GPD), and wherein the one or more heterologous nucleic acids encode valencene synthase.

### Claim 173 (depends on 163)

A method for producing a terpene comprising:
contacting the genetically modified microorganism of claim 163 with a feedstock comprising a carbon source, and
culturing the microorganism under conditions in which the terpenes are produced from the feedstock.

### Claim 174 (depends on 166)

A method for producing a terpene comprising:
contacting the genetically modified microorganism of claim 166 with a feedstock comprising a carbon source, and
culturing the microorganism under conditions in which the terpenes are produced from the feedstock.

### Claim 175 (depends on 170)

A method for producing a terpene comprising:
contacting the genetically modified Candida viswanathii yeast of claim 170 with a feedstock comprising a carbon source, and
culturing the microorganism under conditions in which the terpenes are produced from the feedstock.

### Claim 176 (depends on 173)

The method of claim 173, wherein the feedstock comprises one or more saturated fatty acids or one or more unsaturated fatty acids; or one or more saturated fatty acids and one or more unsaturated fatty acids.

### Claim 177 (depends on 176)

The method of claim 176, wherein the feedstock comprises one or more fatty acids chosen from oleic acid, palmitoleic acid, erucic acid, linoleic acid, palmitic acid, caproic acid, enanthic acid, caprylic acid pelargonic acid, capric acid, undecylic acid, lauric acid, myristic acid, pentadecanoic acid, margaric acid, stearic acid arachidic acid, behenic acid, tridecylic acid, and linolenic acid.

### Claim 178 (depends on 177)

The method of claim 177 wherein the feedstock comprises oleic acid.

### Claim 179 (depends on 173)

The method of claim 173, wherein the feedstock comprises one or more vegetable oils, derivatives thereof, or byproducts thereof.

### Claim 180 (depends on 179)

The method of claim 179, wherein the feedstock comprises crude palm oil (CPO).

### Claim 181

A genetically modified yeast comprising one or more heterologous nucleic acids encoding phytoene synthase, geranylgeranyl diphosphate synthase and phytoene desaturase, wherein the amount and/or activity of a Ras2 protein has been decreased.

### Claim 182

A genetically modified yeast comprising one or more heterologous nucleic acids encoding geranylgeranyl diphosphate synthase, phytoene desaturase and bifunctional lycopene cyclase/phytoene synthase, wherein the amount and/or activity of a Ras2 protein has been decreased.

### Claim 183

A genetically modified yeast comprising one or more heterologous nucleic acids encoding geranylgeranyl diphosphate synthase, phytoene desaturase, bifunctional lycopene cyclase/phytoene synthase, β-carotene ketolase, β-carotene hydroxylase, astaxanthin synthase, and cytochrome p450 reductase, wherein the amount and/or activity of a Ras2 protein has been decreased.
